
Copenhagen-based life science investor that holds the Novo Group and manages the Novo Nordisk Foundation's assets

Corporate venture fund of Roche investing in pharmaceutical, diagnostic and digital health companies

Roche Venture Fund is the corporate venture arm of Roche, the healthcare group. It invests in life science companies with the aim of encouraging new ideas, guiding growing businesses and producing financial returns for Roche.
Life science companies that can become commercially successful.
Profile written by TrustList from the business's own published information, Oct 2026.
2 images - click to enlarge
As of 2026-10-10. Organic ranks only; sponsored placements are never ranks.
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Roche Venture Fund.
Similar listings buyers compare against this one.

Copenhagen-based life science investor that holds the Novo Group and manages the Novo Nordisk Foundation's assets

Chicago private equity firm investing only in middle-market healthcare and life science companies

Technology-focused venture capital fund investing in growing companies across Asia, North America and Europe

Seed-only venture firm backing engineering-minded founders with equity or SAFE investments

A liquidity and market-making services provider for Web3 token projects and exchanges

European technology investor with offices in Paris, London, Seoul and Singapore, linking start-ups to Asia
Everything here links back to the same verified catalogue. Pick your next stop.